Assisted Reproductive Technology (ART) Market Analysis and Size
Data Bridge Market Research analyses that the assisted reproductive technology (ART) market which was USD 26.28 billion in 2022, is expected to reach USD 50.10 billion by 2030, at a CAGR of 8.4% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Rising infertility rates, improved ART success rates, and increasing disposable income in developing countries are expected to drive industry growth during the forecast period. According to the World Health Organization Statistics 2020, approximately 186 million people worldwide face infertility issues.
COVID-19 Impact on the Assisted Reproductive Technology (ART) Market
The pandemic had a negative impact on the industry because of the shutdown of operations and subsequent decrease in patient care volumes. Post-pandemic, technological advancement and telehealth adoption in the field of ART are expected to boost industry growth. Telehealth adoption in ART services is still in its early stages. Nonetheless, it has enormous future potential due to remote monitoring and continuous management benefits.
Global Assisted Reproductive Technologies (ART) Market Scope and Market Size
Assisted reproductive technology (ART) market is segmented on the basis of procedure, technology, product type and end-use. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Assisted reproductive technology (ART) market has also been segmented on the basis of technology into in-vitro fertilization (IVF), artificial insemination - intrauterine insemination (AI-IUI), frozen embryo replacement (FER) and others. In-vitro fertilization (IVF) has been further segmented into IVF with intracytoplasmic sperm injection (ICSI), IVF without ICSI.
Assisted Reproductive Technology (ART) Market Country Level Analysis
Assisted reproductive technology (ART) market is analysed and market size insights and trends are provided by country, procedure, technology, product type and end use as referenced above.
The countries covered in the assisted reproductive technology (ART) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The persuasive Assisted Reproductive Technology (ART) Market report makes visualize what the Healthcare industry is doing which lends more credibility and trust. Moreover, this market report also makes available strategic profiling of key players in the Healthcare industry, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market. A meticulous analysis of factors influencing the investment is also provided which forecasts impending opportunities for the businesses and develops the strategies to boost return on investment (ROI). Market segmentation analyses the usage of the product with respect to its applications, end user or with respect to geography.
Access Full Report:-
Competitive Landscape and Assisted Reproductive Technology (ART) Market Share Analysis
The assisted reproductive technology (ART) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to assisted reproductive technology (ART) market.
Some of the major players operating in the assisted reproductive technology (ART) market are:
California Cryobank (U.S.)
Bloom Fertility Centre (India)
Anecova (Switzerland)
CooperSurgical (U.S.)
Merck KGaA (Germany)
Ferring B.V. (Switzerland)
FUJIFILM Irvine Scientific (U.S.)
Genea Limited (Australia)
Nidacon International AB (Sweden)
Celmatix Inc. (U.S.)
Esco Micro Pte Ltd. (Singapore)
INVO Bioscience (U.S.)
Laboratoire CCD (France)
Nikon Instruments Inc. (U.S.)
ICU Medical, Inc. (U.S.)
Request Access for Sample Report:-
Major TOC of the Report
INTRODUCTION
MARKET SEGMENTATION
MARKET OVERVIEW
EXECUTIVE SUMMARY
Get TOC of the Report:-
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Browse Related Reports@
#Assisted-Reproductive-Technology-(ART)-Market, #Healthcare, #Assisted-Reproductive-Technology-(ART)-Market-Share, #Assisted-Reproductive-Technology-(ART)-Market-Size, #Assisted-Reproductive-Technology-(ART)-Market-Insight,
Comments